GT Biopharma Inc (GTBP)
3.05
+0.08
(+2.69%)
USD |
NASDAQ |
Nov 04, 16:00
2.95
-0.10
(-3.28%)
After-Hours: 20:00
GT Biopharma Shareholders Equity (Quarterly): 5.508M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 5.508M |
March 31, 2024 | 5.312M |
December 31, 2023 | 7.476M |
September 30, 2023 | 10.00M |
June 30, 2023 | 11.76M |
March 31, 2023 | 13.05M |
December 31, 2022 | 11.73M |
September 30, 2022 | 15.95M |
June 30, 2022 | 15.44M |
March 31, 2022 | 17.79M |
December 31, 2021 | 21.91M |
September 30, 2021 | 32.04M |
June 30, 2021 | 36.46M |
March 31, 2021 | 24.19M |
December 31, 2020 | -29.43M |
September 30, 2020 | -29.61M |
June 30, 2020 | -27.33M |
March 31, 2020 | -20.69M |
December 31, 2019 | -19.14M |
September 30, 2019 | -18.12M |
June 30, 2019 | 9.145M |
March 31, 2019 | 10.18M |
December 31, 2018 | 11.54M |
September 30, 2018 | 13.48M |
June 30, 2018 | 246.23M |
Date | Value |
---|---|
March 31, 2018 | 252.43M |
December 31, 2017 | 251.86M |
September 30, 2017 | 253.89M |
June 30, 2017 | -19.92M |
March 31, 2017 | -17.94M |
December 31, 2016 | -18.76M |
September 30, 2016 | -17.04M |
June 30, 2016 | -15.66M |
March 31, 2016 | -20.05M |
December 31, 2015 | -50.40M |
September 30, 2015 | -24.38M |
June 30, 2015 | -22.73M |
March 31, 2015 | -49.76M |
December 31, 2014 | -29.40M |
September 30, 2014 | -10.75M |
June 30, 2014 | -6.814M |
March 31, 2014 | -6.552M |
December 31, 2013 | -6.181M |
September 30, 2013 | -5.828M |
June 30, 2013 | -5.519M |
March 31, 2013 | -5.213M |
December 31, 2012 | -6.246M |
September 30, 2012 | -6.111M |
June 30, 2012 | -6.421M |
March 31, 2012 | -5.263M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-29.61M
Minimum
Sep 2020
36.46M
Maximum
Jun 2021
5.391M
Average
11.73M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.267M |
Total Liabilities (Quarterly) | 3.759M |